公司資料
Thermo Fisher Scientific Inc 股價、新聞與催化劑
- 股票代碼:
- TMO
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
585.51 USD (-0.47%)
收盤價
最後更新: 2026年8月17日
179B USD
市值
股價為何變動
As of Aug 17, 2026, TMO closed down 0.47% at $585.51. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Thermo Fisher Scientific is a life sciences tools and diagnostics company that supports drug discovery, clinical development, manufacturing, and laboratory workflows. Its role is foundational: it powers much of the biotech ecosystem without being a therapeutic developer itself.
所在地與產業分類
Headquartered in the United States and listed on NYSE, Thermo Fisher has a global footprint across research, clinical, and industrial markets. It sits in life sciences tools and diagnostics rather than therapeutic biotech.
商業模式特徵
The company generates revenue through instruments, consumables, services, and workflow solutions. Investors watch lab demand, biopharma spending, diagnostics activity, and the health of research budgets because they drive recurring usage across the platform.
生技產業定位
Thermo Fisher sits at the infrastructure layer of biotech and pharma. It is less binary than drug-development names, but it is deeply tied to the industry’s overall spending cycle and research intensity.
未來催化劑
- Thermo Fisher’s next three months are mostly about bioprocess demand, clinical research spend, and whether biotech funding trends are finally turning from soft to stable. That readout matters because it decides whether the asset is ready for a larger and more expensive development step. If the data come in cleanly, the market tends to give the broader platform behind the program more credit.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。